Desperate for five more years in power, India's Hindu nationalist government will woo rural and urban middle-class voters with farm relief measures and tax cuts, said officials privy to plans for the final budget before a general election.
Stung by opposition victories in three state polls last month, and needing to call a national election by May, prime minister Narendra Modi is facing growing discontent over depressed farm incomes and doubts over whether his policies are creating enough jobs.
The electoral compulsions mean that major economic reforms, such as tax cuts for bigger companies and plans to bring down the budget deficit, could be put on hold at least until after the election, the sources said.
Piyush Goyal, India's interim finance minister, will present the budget on February 1, in the absence of finance minister Arun Jaitley, who is currently in the United States for medical treatment.
The higher spending, along with a shortfall in tax collections, will push the fiscal deficit up to the equivalent of 3.5 per cent of gross domestic product for the year ending in March, overshooting a previous 3.3 per cent target, according to one of the sources with direct knowledge of budget discussions.
That would fit with the expectations of a Reuters poll of economists.
The source said there was a chance that the government could take corrective action in March, hoping that by that time the election schedule will be settled and the public focus will shift towards campaigning.
"We may resort to spending cuts in March to contain the fiscal deficit," the source said.
The finance ministry had cut capital and other spending amounting to Rs 750.8 billion ($10.55bn) in the last financial year ending in March 2018. But Modi’s government has been stepping back from such fiscal rectitude in recent months.
In its desperation to find ways to pay for pre-election spending, the government has also pressed the central bank to part with more of its reserves, causing a rift that culminated in the resignation of the bank's governor last month.
"This is an election budget, and most of the economic reforms have been put on hold," said another official, adding the government could defer any decision on business demands for a cut in corporate tax.
Business leaders said the government still has to meet its three-year old promise of cutting the corporate tax rate for larger companies to 25 per cent from 30 per cent.
"Although all over the world overall tax has started coming down, India is one of the large economies which has corporate taxes on the higher side," said Rohinton Sidhwa, partner at Deloitte India.
The budget, which is interim and is likely to be followed by a full one in July, is expected to project economic growth of around 7.5 per cent for the next financial year, while expanding capital spending on railways, roads, ports by seven to eight per cent, and estimating an increase in revenue of about 15 per cent, officials said.
But the main focus will be on the rural sector and the urban middle-class.
The government is ready with relief measures for farmers, benefits for unemployed youth, higher tax exemptions for the middle class and small businesses, the officials said.
According to two government sources, the farm relief package itself could run to at least $14bn if the government is to have a meaningful impact on which way voters lean in rural areas, where two-thirds of Indians live.
The pre-election giveaways could give the economy short term momentum, but result in a hangover after the election.
Credit rating agencies have warned that without bringing down other spending, a higher farm subsidy bill will increase future fiscal deficits.
"In the absence of new revenue boosting measures, the policies will collectively make it harder for the government to achieve its fiscal consolidation objectives," Moody's Investors Service said last week.
Looking For Jobs
Though he has spent big on building roads and railways, Modi has been fiscally conservative for most of his time in power, helping to bring retail inflation to near two per cent from double-digits during the previous government's time.
Last month's state election upsets have made the Modi government shed some of that caution.
Despite expanding by seven per cent plus annually - the fastest pace among major economies, the uneven nature of the growth has meant that the economy has failed to create enough jobs for millions of youth entering the workforce each year.
Merchandise exports have shown no signs of growth in last four years, and some textile, leather and engineering goods producers have shifted production abroad.
Earlier this month, the Centre for Monitoring Indian Economy (CMIE), a leading independent think tank, issued a report showing the country lost as many as 11 million jobs last year, making it even harder for new entrants to the labour market.
Last week, Raghuram Rajan, former governor of the Reserve Bank of India, said India needed flexible labour and land laws, and to fix glitches in the Goods and Services Tax, launched as a major tax reform in 2017.
"We need two percentage points more growth to provide those jobs that are needed," said Rajan.
UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.
Investment gap
Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.
Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.
Richard Torbett, ABPI Chief Executive, noted “The UK can lead globally in medicines and vaccines, unlocking billions in R&D investment and improving patient access but only if barriers are removed and innovation rewarded.”
The UK invests just 9% of healthcare spending in medicines, compared with 17% in Spain, and only 37% of new medicines are made fully available for their licensed indications, compared to 90% in Germany.
Expert reviews
Shailesh Solanki, executive editor of Pharmacy Business, pointed that “The government’s own review shows the sector is underfunded by about £2 billion per year. To make transformation a reality, this gap must be closed with clear plans for investment in people, premises and technology.”
The National Institute for Health and Care Excellence (NICE) cost-effectiveness threshold £20,000 to £30,000 per Quality-Adjusted Life Year (QALY) — has remained unchanged for over two decades, delaying or deterring new medicine launches. Raising it is viewed as vital to attracting foreign investment, expanding patient access, and maintaining the UK’s global standing in life sciences.
Guy Oliver, General Manager for Bristol Myers Squibb UK and Ireland, noted that " the current VPAG rate is leaving UK patients behind other countries, forcing cuts to NHS partnerships, clinical trials, and workforce despite government growth ambitions".
Reeves’ push for reform, supported by the ABPI’s Competitiveness Framework, underlines Britain’s intent to stay a leading hub for pharmaceutical innovation while ensuring NHS patients will gain faster access to new treatments.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.